Study Information
Status: Active, Not Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
San Francisco
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Study of the Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System In the Treatment of Subacute and Chronic Subdural HEmatoma (EMBOLISE)
The Embolise Study is designed to evaluate the safety and effectiveness of Onyx™ LES embolization of the MMA as an adjunct to conventional treatment (surgery or observation) for symptomatic subacute or chronic subdural hematoma.
Location: CPMC (San Francsico: Davies Campus)
Please contact: ClinicalResearch@sutterhealth.org about study EMBOLISE
Principal Investigator
Fabio Settcase, M.D., M.S., FRCPC
Co-Investigator(s)
Related Studies
GXCA
Gene Expression of Cerebral Aneurysms // [EMC]
Investigator: Lawrence Dickinson, M.D
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Use EHRs and survey data to characterize migraineurs at Sutter Health by demographic, comorbidity, symptom, and care gap profiles, to see if tx needs are met.
Mindfulness and Migraine: A Randomized Controlled Trial
Conduct a randomized controlled feasibility trial of mindfulness-based stress reduction for patients with moderate-to-severe migraine headache.
Investigator: Sylvia Sudat, PhD
Genetics and Comorbidity of Migraine
Identify common genetic variants for migraine to determine whether there are single nucleotide polymorphisms associated with migraine.